Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
- March -
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
- 2018 -
2019
-
2020
-
2021
-
2022
-
2023
-
2024
March 2018 - 17 products
IP
CI
VICKS AngiMed Citron
24
PR
PR
k.A.
Lozenges: 2 Active Agents
Procter & Gamble
International
Operations SA
D
FB
G
IP
CI
CM
Amavita Dextromethorphan-N
200 ml
PR
PR
k.A.
Sirup: Dextromethorphanum 25 mg
Amavita Health Care AG
B
FB
G
IP
CI
Solacutan 3%
25 g
14.87
32.60
10 %
Gel: Diclofenacum Natricum 30 mg
Dermapharm AG
B / SL / SG
FB
G
IP
CI
Solacutan 3%
50 g
26.18
44.90
10 %
Gel: Diclofenacum Natricum 30 mg
Dermapharm AG
B / SL / SG
FB
G
IP
CI
Solifenacin Spirig HC 5 mg
30
17.90
35.90
10 %
Coated tablets: Solifenacini Succinas 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Solifenacin Spirig HC 5 mg
90
49.94
70.80
10 %
Coated tablets: Solifenacini Succinas 5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Solifenacin Spirig HC 10 mg
30
21.39
39.70
10 %
Coated tablets: Solifenacini Succinas 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Solifenacin Spirig HC 10 mg
90
59.69
81.40
10 %
Coated tablets: Solifenacini Succinas 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Modigraf 0,2 mg
50
47.96
68.60
10 %
Granulat zur Herstellung einer Suspension zum Einnehmen: Tacrolimusum
Astellas Pharma AG
A / SL
FB
G
L
IP
Modigraf 1 mg
50
217.71
253.20
10 %
Granulat zur Herstellung einer Suspension zum Einnehmen: Tacrolimusum 1 mg
Astellas Pharma AG
A / SL
FB
G
IP
Brilique 90 mg
10
PR
PR
k.A.
Melting tablets: Ticagrelorum 90 mg
AstraZeneca AG
●
B
FB
G
IP
CI
Solacutan 3%
100 g
PR
PR
k.A.
Gel: Diclofenacum Natricum 30 mg
Dermapharm AG
B
FB
G
IP
CI
Ph
Angocin
50
PR
PR
k.A.
Coated tablets: 2 Active Agents
Max Zeller Söhne AG
D
FB
G
IP
CI
Ph
Angocin
100
PR
PR
k.A.
Coated tablets: 2 Active Agents
Max Zeller Söhne AG
D
FB
G
IP
CI
Ph
Angocin
200
PR
PR
k.A.
Coated tablets: 2 Active Agents
Max Zeller Söhne AG
D
FB
G
IP
CI
Xermelo 250 mg
90
PR
PR
k.A.
Coated tablets: Ethylis Telotristatas 250 mg
Future Health Pharma
GmbH
B
FB
G
IP
CI
CM
Amavita Dextromethorphan
16
PR
PR
k.A.
Hustentabletten: Dextromethorphanum 25 mg
Amavita Health Care AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
